Monitoring kidney function and albuminuria in patients with diabetes (Q27691297)

main subject

cardiovascular disease

1 reference

3 July 2020

1 reference

3 July 2020

1 reference

3 July 2020

1 reference

26 January 2021

Heerspink HJ

1

1 reference

Holtkamp FA

series ordinal

2

1 reference

de Zeeuw D

series ordinal

3

1 reference

Ravid M

series ordinal

4

1 reference

language of work or name

English

0 references

publication date

May 2011

1 reference

1 May 2011

6 references

14 March 2019

24 March 2019

17 June 2019

29 May 2020

3 July 2020

26 January 2021

7 references

14 March 2019

24 March 2019

17 June 2019

29 May 2020

3 July 2020

26 January 2021

34 Suppl 2

1 reference

page(s)

S325-9

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives

copyright license

6 references

14 March 2019

24 March 2019

17 June 2019

29 May 2020

3 July 2020

26 January 2021

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Executive summary: Standards of medical care in diabetes--2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Supramaximal dose of candesartan in proteinuric renal disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Cystatin C, albuminuria, and mortality among older adults with diabetes.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Assessing kidney function--measured and estimated glomerular filtration rate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632201

Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria

27 November 2018

1 reference

12 December 2020

Pharmacology: defining the optimal dose of a new drug: a crucial decision

1 reference

12 December 2020

1 reference

12 December 2020

Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

1 reference

12 December 2020

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus

1 reference

12 December 2020

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

12 December 2020

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

12 December 2020

A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function

1 reference

12 December 2020